One Contrarian Reason to Like Advanced Micro Devices, Inc. (AMD) and SAIC, Inc. (SAI)
Yesterday, shareholders in chipmaker Advanced Micro Devices, Inc. (NYSE:AMD) and defense contractor SAIC, Inc. (NYSE:SAI) got what seemed like bad news.
Posts Tagged ‘NASDAQ:VRTX’
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson's hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares of Onyx Pharmaceuticals, ...
Should You Buy Regeneron Pharmaceuticals Inc (REGN)?
If you were to ask many investors, hedge funds are viewed as delayed, outdated investment vehicles of an era lost to time.
Vertex Pharmaceuticals Incorporated (VRTX), Merck & Co., Inc. (MRK): Gilead Sciences, Inc. (GILD) Races Against Competitors for an Oral Hepatitis-C Cure
One of the company's ushering in the next generation of hepatitis-C treatment is Gilead Sciences, Inc. (NASDAQ:GILD).
What Hedge Funds Think About Vertex Pharmaceuticals Incorporated (VRTX)
In the 21st century investor’s toolkit, there are tons of metrics market participants can use to track the equity markets.
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
In the 21st century investor’s toolkit, there are tons of metrics shareholders can use to track publicly traded companies.
Do Hedge Funds and Insiders Love Alexion Pharmaceuticals, Inc. (ALXN)?
In the 21st century investor’s toolkit, there are dozens of indicators investors can use to analyze Mr. Market.
Hedge Funds Are Crazy About BioMarin Pharmaceutical Inc. (BMRN)
In the financial world, there are dozens of gauges shareholders can use to analyze stocks. Two of the most under-the-radar are hedge fund and insider trading sentiment.
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times.
Exelixis, Inc. (EXEL), Vertex Pharmaceuticals Incorporated (VRTX), Celgene Corporation (CELG): Want Multibaggers? Consider These 3 Biotech Companies
In after hours trading on April 18, a few hours after the release of my previous article focusing on Exelixis, Inc.
Dendreon Corporation (DNDN), Vertex Pharmaceuticals Incorporated (VRTX): The Rise and Fall of the Fastest Growing Drug in the World
If you've ever taken the time to really follow the biopharmaceutical sector, you know very well that failures are a dime a dozen, and success stories are few and far between.
Vertex Pharmaceuticals Incorporated (VRTX), Green Mountain Coffee Roasters Inc. (GMCR): Stocks That Could Become Tomorrow’s Big S&P Winners
The S&P 500 includes 500 of the biggest stocks in the market.
3D Systems Corporation (DDD), Synovus Financial Corp. (SNV), Vertex Pharmaceuticals Incorporated (VRTX): These “Pure Growth” Stocks Have Been Trouncing the Market
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Vertex Pharmaceuticals Incorporated (VRTX): This Biotech’s Cystic Fibrosis Treatments Could Catapult It To Profitability
Cystic fibrosis (CF), a genetic disorder that affects the lungs, the pancreas, liver, and intestine, is the second most common inherited disorder in the United States, after sickle...
Array Biopharma Inc (ARRY), Vertex Pharmaceuticals Incorporated (VRTX): This Week in Biotech
With the SPDR S&P Biotech Index up 29% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Vertex Pharmaceuticals Incorporated (VRTX), Accelerate Diagnostics Inc (AXDX), Lifevantage Corporation (LFVN) – Pharmaceuticals: One Short, One Buy, One Strong Buy
Biotechnology stocks are usually valued on the potential of their pipelines, especially if there is no drug already in the market.
Gilead Sciences, Inc. (GILD) 2 Wins for Gilead: HIV Present, HCV Future
Gilead Sciences, Inc. (NASDAQ:GILD)' shares surged over 5% in after-hours trading on Thursday after the company announced its second-quarter earnings before giving up some of...
Three Key Takeaways From Johnson & Johnson (JNJ)’s Q2
Johnson & Johnson (NYSE:JNJ) reported its second quarter on Tuesday, and turned in some positive numbers. Revenue grew 8.5%, year-over-year, up to $17.9 billion.
Johnson & Johnson (JNJ) Stock Is Always a Buy (If You Hold Long Enough)
To prove my point, I looked at the multi-year chart and picked out some of the peaks.
Hewlett-Packard Company (HPQ), Sony Corporation (ADR) (SNE): Can These Companies Continue Their Bull Run?
When the stock price of a company increases significantly, investors are curious to know whether it is likely to increase further.
Abbott Laboratories (ABT), AbbVie Inc (ABBV): This FDA Approval Is Exciting News for Hepatitis-C Patients
Hepatitis-C is a contagious virus that attacks the liver and can be found in acute or chronic forms.
Johnson & Johnson (JNJ), Vertex Pharmaceuticals Incorporated (VRTX): Inside HCV, An Interview with Janssen
Our job here is to examine companies through an investing perspective.
Novartis AG (ADR) (NVS), Alexion Pharmaceuticals, Inc. (ALXN), Celgene Corporation (CELG), Onyx Pharmaceuticals, Inc. (ONXX): 4 Companies Riding the Orphan Drug Rocket
A recent report by EvaluatePharma claims that sales of orphan drugs -- ones that target rare diseases -- will grow at twice the rate of the overall prescription market.
Johnson & Johnson (JNJ) Takes a Breather
After a 12-week run of seeing its share price rise for the week, Johnson & Johnson (NYSE:JNJ) stock fell last week.
This Metric Says You Are Smart to Sell Vertex Pharmaceuticals Incorporated (VRTX)
Is Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) the right investment to pursue these days? The smart money is getting less optimistic.
PDL BioPharma Inc. (PDLI), AbbVie Inc (ABBV): Two Scariest Dividend Stocks in Health Care
Combining nice dividends with a growing industry that comprises roughly one-fifth of the nation's GDP should make for an attractive stock -- in theory.
Vertex Pharmaceuticals Incorporated (VRTX): What You Need To Know
What's the source of your investment strategy? Many look to great investors like Warren Buffett for guidance on how to invest.
Express Scripts Holding Company (ESRX), And More Favs From Janus Fund
Janus Fund (JANDX) bares the name of the fund family behind it. The flagship offering focuses on growth.
Johnson & Johnson (JNJ), Pfizer Inc. (PFE): Take Two Dividend Stocks and Call Me in the Morning
Dividend stocks can be a great addition to your portfolio, especially pharmaceutical dividend stocks that offer a bit of stability in rocky times.
Vertex Pharmaceuticals Incorporated (VRTX) Just Jumped & Could Jump Again
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) have appreciated significantly in 2013 so far, and it seems that the trend might continue for the rest of the year.
Sarepta Therapeutics Inc (SRPT), Pharmacyclics, Inc. (PCYC): Are These Billion-Dollar Biotechs Overvalued?
Biotechs with market caps of a billion dollars or more are a dime a dozen. Well, actually, they're more like $12 billion or more a dozen, but you get the point.
Vertex Pharmaceuticals Incorporated (VRTX), MannKind Corporation (MNKD): Want to Invest in Biotech? Think Like a Venture Capitalist
They're demanding. They take risks -- but only calculated ones. And they ask lots of penetrating questions to understand as much as possible before putting a dime on the line.
Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two
As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.
Alexion Pharmaceuticals, Inc. (ALXN), Vertex Pharmaceuticals Incorporated (VRTX): Orphan Drug Biotechs Do It Best
There are many biotech stocks to choose from that have long-lasting value.
Micron Technology, Inc. (MU), and How to Profit From These Double Digit Growers
Exchange-traded funds offer a convenient way to invest in sectors or niches that interest you.
Johnson & Johnson (JNJ), And Why The FDA’s Latest Designation is More Bling Than Bite
Johnson & Johnson (NYSE:JNJ) announced on Monday that it had received a third Breakthrough Therapy Designation for the blood cancer drug ibrutinib that it's developing with Pharmacyclics...
The Perfect Cure for Hepatitis C? – Gilead Sciences, Inc. (GILD), Johnson & Johnson (JNJ)
Gilead Sciences, Inc. (NASDAQ:GILD)' sofosbuvir with Johnson & Johnson (NYSE:JNJ) and Medivir's simeprevir are a match made in heaven.
Hepatitis C In Play for 2013?: Idenix Pharmaceuticals, Inc. (IDIX)
In the world of biotech stocks a lot of companies are starting to incorporate Hepatitis C treatments into their pipelines.
This Is One Incredible CEO: Vertex Pharmaceuticals Incorporated (VRTX)
The Motley Fool's readers have spoken, and I have heeded your cries.
The FDA Made Biotech Investing Harder (But More Lucrative): Johnson & Johnson (JNJ)
For instance, it's hard to make money on shoo-in Food and Drug Administration approvals. The approval is already reflected in the price.
Celgene Corporation (CELG): My Favorite Big Biotech for 2013
The biggest biopharmaceutical companies blazed trails and lifted portfolios last year.
Has Gilead Sciences, Inc. (GILD) Become the Perfect Stock?
One thing's for sure: You'll never discover truly great investments unless you actively look for them.
